Literature DB >> 10738309

Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis.

R Simon1, R Desper, C H Papadimitriou, A Peng, D S Alberts, R Taetle, J M Trent, A A Schäffer.   

Abstract

Cancer geneticists seek to identify genetic changes in tumor cells and to relate the genetic changes to tumor development. Because single changes can disrupt the cell cycle and promote other genetic changes, it is extremely hard to distinguish cause from effect. In this article we illustrate how 7 techniques from statistics, theoretical computer science, and phylogenetics can be used to infer and test possible models of tumor progression from single genome-wide descriptions of aberrations in a large sample of tumors. Specifically, we propose 4 tree models for tumor progression inferred from the large ovarian cancer data set described in the first 2 articles in this series. The models are derived from 2 different methods to select the non-random genetic aberrations and 2 different methods to infer the trees, given a set of events. Various aspects of the tree models are tested and extended by 5 methods: overall tests of independence, likelihood ratio tests, principal components analysis, directed acyclic graph modeling, and Bayesian survival analysis. All our methods lead to strikingly consistent conclusions about chromosomal breakpoints in ovarian adenocarcinoma, including (1) the non-random breakpoints in ovarian adenocarcinoma do not occur independently; (2) breakpoints in regions 1p3 and 11p1 are important early events and distinguish a class of tumors associated with poor prognosis; and (3) breakpoints in 1p1, 3p1, and 1q2 distinguish a class of ovarian tumors, and the breaks at 1p1 and 3p1 are associated with poor prognosis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10738309

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

Review 1.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

2.  Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

Authors:  Rodney N Wiltshire; James E Herndon; Annie Lloyd; Henry S Friedman; Darell D Bigner; Sandra H Bigner; Roger E McLendon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression.

Authors:  Swapnali Pathare; Alejandro A Schäffer; Niko Beerenwinkel; Manoj Mahimkar
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

Review 4.  [Genome-wide molecular screening for the identification of new targets in human hepatocellular carcinoma].

Authors:  T Longerich
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

5.  BAC CGH-array identified specific small-scale genomic imbalances in diploid DMBA-induced rat mammary tumors.

Authors:  Emma Samuelson; Sara Karlsson; Karolina Partheen; Staffan Nilsson; Claude Szpirer; Afrouz Behboudi
Journal:  BMC Cancer       Date:  2012-08-15       Impact factor: 4.430

Review 6.  PhyloOncology: Understanding cancer through phylogenetic analysis.

Authors:  Jason A Somarelli; Kathryn E Ware; Rumen Kostadinov; Jeffrey M Robinson; Hakima Amri; Mones Abu-Asab; Nicolaas Fourie; Rui Diogo; David Swofford; Jeffrey P Townsend
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-10-31       Impact factor: 11.414

7.  A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis.

Authors:  Yu-Kang Cheng; Rameen Beroukhim; Ross L Levine; Ingo K Mellinghoff; Eric C Holland; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2012-01-05       Impact factor: 4.475

8.  Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling.

Authors:  Ramon Diaz-Uriarte
Journal:  BMC Bioinformatics       Date:  2015-02-12       Impact factor: 3.169

9.  Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization.

Authors:  Donatella Caserta; Moncef Benkhalifa; Marina Baldi; Francesco Fiorentino; Mazin Qumsiyeh; Massimo Moscarini
Journal:  Mol Cytogenet       Date:  2008-05-20       Impact factor: 2.009

10.  Methods and challenges in timing chromosomal abnormalities within cancer samples.

Authors:  Elizabeth Purdom; Christine Ho; Catherine S Grasso; Michael J Quist; Raymond J Cho; Paul Spellman
Journal:  Bioinformatics       Date:  2013-09-23       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.